Z ika virus (ZIKV) was first isolated from a sentinel monkey from Uganda's Zika forest in 1947 and, until its recent emergence in the Americas, was known as an obscure mosquito-borne flavivirus (1) . In the decades following its discovery, sporadic human ZIKV infections with mild signs and symptoms were reported in a few countries in Africa and Southeast Asia. After several explosive outbreaks in Micronesia in 2007 and French Polynesia in 2013-2014, ZIKV rapidly swept through South and Central America in 2015. Early in 2016, the World Health Organization declared the current ZIKV epidemics a public health emergency of international concern, owing to the unexpected causal link to congenital brain abnormalities, especially microcephaly, during pregnancy (2, 3) . Investigations with clinical materials and animal models have provided solid evidence that ZIKV directly targets neuronal progenitor cells (NPCs), leading to microcephaly as well as other severe pathological outcomes (4) (5) (6) (7) (8) (9) .
ZIKV contains a positive-sense 11-kb genome RNA that encodes three structural proteins (C, prM, and E) and seven nonstructural proteins. ZIKV strains can be divided into the African and Asian lineages (10) , and the contemporary strains circulating in Pacific islands and the Americas are likely to have evolved from a common ancestral strain in Southeast Asia (11) . However, there is serological evidence that ZIKV had been circulating in Southeast Asia for many years (10, 12) . Why was microcephaly not recognized earlier? Besides the potential impact of herd immunity and the lack of diagnostics and surveillance in epidemic areas, one plausible hypothesis is that ZIKV has acquired some adaptive mutations to become more virulent to the human fetal brain. Some preliminary results from cell lines indicate strain-specific effects in ZIKV-infected cells (13, 14) . Whether contemporary ZIKV strains are more likely to cause severe microcephaly in the fetus remains an open question.
We first investigated the in vivo neurovirulence phenotypes of three contemporary ZIKV strains (MTQ/2015, VEN/2016, and SAM/2016) isolated in 2015-2016 (6, 15, 16 ) and compared them with the phenotypes of their Asian ancestral strain (CAM/2010) isolated in Cambodia in 2010 (17 ) . We used one-day-old neonatal mice, as this stage of development is analogous to the second trimester of pregnancy in humans. Upon intracerebral injection (18, 19) , all three contemporary strains led to 100% mortality in neonatal mice, with typical neurological manifestations such as inactivity, motor weakness, and bilateral hind limb paralysis. By contrast, CAM/2010 killed only 16.7% animals (Fig. 1A) . Nevertheless, in vitro cell culture-based studies revealed that the contemporary strain VEN/2016 showed similar growth and plaque characteristics to those of CAM/2010 ( fig. S1 ). These results show that the contemporary strains of ZIKV are more neurovirulent in mice than their ancestral strain CAM/2010.
To determine whether the observed neurovirulence phenotype is directly associated with microcephaly, we further compared the contemporary and ancestral strains in an established mouse embryonic microcephaly model (4) . Littermate brains were infected with the two ZIKV strains at embryonic day 13.5 (E13.5), which corresponds to infection at the first trimester of pregnancy in humans, a time point that is associated with the development of fetal brain abnormalities (20) . Inspection of the mice at E18.5 revealed that VEN/2016 infection resulted in brains exhibiting a substantial degree of microcephaly (Fig. 1B) , including cortical thinning ( S4B ). Thus, as compared with the ancestral strain, the contemporary ZIKV strain is more virulent to the mouse brain and causes a more severe microcephaly phenotype in the embryonic brain.
We then sought to identify the genetic determinants for the observed virulence phenotype. Genome sequence alignment, with the ancestral strain CAM/2010 as a reference strain, revealed that contemporary ZIKV strains harbor a number of substitutions of amino acids throughout the genome ( fig. S5 ). We mapped these amino acid substitutions on a maximum likelihood tree ( fig. S6 ) and found a positive correlation between the evolution of ZIKV of the Asian lineage and sampling dates ( Fig. 2A) . Further coalescent analysis indicated that multiple critical residue substitutions have arisen at different time points before the South American outbreak and have been maintained stably in the contemporary epidemic strains (Fig. 2B and fig. S7 S8 , B and C). Of all mutants, the S139N mutant virus exhibited the greatest neurovirulence in neonatal mice (Fig. 3A) . More importantly, a single reverse substitution, N139S, of the parental virus VEN/2016 significantly decreased mortality caused by the virus in neonatal mice (Fig. 3B and fig. S9 ). We further characterized the infectivity of the S139N and WT viruses in human NPCs (hNPCs) ( fig. S10 ) derived from human embryonic stem cells (5 ).
Our results confirmed that S139N showed enhanced replication in hNPCs (Fig. 3C ) and caused more extensive cell death compared with the WT virus (Fig. 3D) . Similarly, the S139N mutant showed enhanced viral replication in mNPCs compared with the WT virus ( fig. S11A ). Finally, we tested the effect of the S139N substitution in the embryonic microcephaly model. Infection of the S139N mutant virus led to a more severe microcephalic phenotype (Fig. 4A ) and thinner cortex (Fig. 4B and fig. S11B ) than did infection of the WT virus. Specifically, the S139N mutant virus showed a more robust infection of the NPCs of the embryonic brains (fig. S11, C and D), accompanied by more cell death in the cortical plate (Fig. 4C) . Furthermore, the S139N mutant disturbed the NPC proliferation and differentiation more significantly than did the WT virus (Fig. 4D and fig. S12 ). As expected, the N130S mutant virus caused much less cell death than the S139N mutant in different regions of the brain, similar to the WT virus ( fig. S13) .
Bioinformatic analysis had identified a panel of substitutions that could have given rise to the different biological phenotypes of ZIKV (11, 21, 22) . However, none of these predications have been validated experimentally. Our results from reverse genetics and mouse neurovirulence studies provide experimental evidence that a single S139N substitution significantly enhances ZIKV infectivity in both human and mouse NPCs and leads to more severe microcephaly in fetal mice. Coalescent analysis indicated that the ZIKV S139N substitution first emerged in May 2013 (95% highest probability density intervals: November 2012 to October 2013), a few months before the 2013 outbreak in French Polynesia (21, 23) , and was then stably maintained in the epidemic strain during subsequent spread to the Americas (Fig. 2) . The emergence of the S139N substitution correlates with reports of microcephaly and other severe neurological abnormalities, including 2 of 4 Guillain-Barré syndrome (24, 25) . Our findings offer an explanation for the unexpected causal link of ZIKV to microcephaly and will help to clarify how ZIKV evolved from an innocuous mosquito-borne virus into a congenital pathogen with global impact. Structural modeling based on dengue virus, a closely related flavivirus member, indicates that residue 139, referred to as residue 17 of prM protein, is fully exposed on the surface of prM-E heterodimers or immature particles (fig. S14 ).
The prM protein of flavivirus is required for viral maturation, egress, and secretion, and the pr domain is thought to prevent premature fusion within the infected cells (26) . Flavivirusinfected cells contain a mixture of immature, partially mature, and mature particles (27) . A recent study showed that the first 40 amino acids of the pr domain are involved in the interactions within trimeric spikes in the immature virus particle and affect the dynamics of conformational changes (28) . The S139N substitution might have some effects on the transition of ZIKV from the immature to the mature virion, and the heterogeneity in maturity of progeny virions might thus affect viral fitness as well as neurovirulence. Our results also show that the ancestral Asian strain CAM/2010 can result in a mild microcephaly phenotype in mouse fetus (Fig. 1) , and the N139S reverse mutant virus of contemporary ZIKV strain retains some neurovirulence to neonatal mice (Fig. 3B) . Thus, further work will be required to identify additional viral genetic determinants 3 of 4 and host factors that might affect ZIKV pathogenesis. In addition, enhancement of vector infectivity by specific amino acid substitutions has been reported in ZIKV and other mosquito-borne viruses (29, 30) , but the potential relationship between epidemic potential and disease severity is still under investigation.
